Neoaska Pharma Private Limited

Neoaska Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U74999TG2017PTC119969 Incorporated 10 October 2017 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹3.17 Lakh
▼ 53% YoY
Net loss · FY 2025
₹43.01 Lakh
Latest filing
EBITDA · FY 2025
-₹4.67 Lakh
EBITDA margin -147.3%
Authorised capital
₹150 Cr
Registered with MCA
Paid-up capital
₹23.12 Cr
Issued & subscribed
Satisfied charges
₹18.96 Cr
No open charges
Company age
9 yrs
Est. 2017
Employees · EPFO
30
Provident fund records

About Neoaska Pharma Private Limited

Data last updated:

Neoaska Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Omnicare Drugs India Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 October 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2017PTC119969. Its GSTIN is 36AAFCN8041A1ZS (Telangana). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹150 Cr and a paid-up capital of ₹23.12 Cr. It was formerly known as Neumedica Life Sciences Private Limited. It is led by directors Nagaraja Rathan Yancharla and Pakanati Venkata Raghava Reddy.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Door No 1 – 66/1/Ceo/1/Ph Plot No 1 Ceo Enclave, Sy No. 136/2 And 136/4 Gachibowli Hyderabad, Telangana, India – 500032.

As per the financials filed for FY 2025, the company reported a revenue of ₹3.17 Lakh, a decline of 53% compared to the previous year. For the same year it recorded a net loss of ₹43.01 Lakh and EBITDA of -₹4.67 Lakh (EBITDA margin -147.3%).

The company has about 30 employees on its provident fund (EPFO) records.

As per MCA filings, the company has satisfied charges of ₹18.96 Cr on record. Court records list 12 cases involving the company, including 1 filed by the company and 11 filed against it; 2 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tatvalegal.com.

Company details

CIN U74999TG2017PTC119969
Registration Number 119969
Incorporation Date 10 October 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Omnicare Drugs India Private Limited
Compliance Status Active Compliant

Name history

Neoaska Pharma has undergone 3 name changes throughout its history. The company was previously known as Neo Aska Pharma Private Limited, Neumedica Life Sciences Private Limited, and Omnicare Aska Pharma Private Limited. The current legal name is Neoaska Pharma Private Limited.

Company NameStatus
Neoaska Pharma Private LimitedCurrent
Neo Aska Pharma Private LimitedPrevious
Neumedica Life Sciences Private LimitedPrevious
Omnicare Aska Pharma Private LimitedPrevious

Contact details

Neoaska Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Door No 1 – 66/1/Ceo/1/Ph Plot No 1 Ceo Enclave, Sy No. 136/2 And 136/4 Gachibowli Hyderabad, Telangana, India – 500032
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Neoaska Pharma Private Limited, buy the company report.

Comprehensive company report
Neoaska Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Neoaska Pharma Private Limited

FY 2025 filings available

Neoaska Pharma Private Limited reported revenue of ₹3.17 Lakh (down 53% YoY) for FY 2025.

Revenue · FY 2025
₹3.17 Lakh ▼ 53%
Net loss · FY 2025
₹43.01 Lakh
EBITDA · FY 2025
-₹4.67 Lakh margin -147.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 53%
EBITDA CAGR growth
1 year
▲ 93%
3 years · compounded
▼ 16%

Revenue fell 53% in the latest year. EBITDA rose 93% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹4.67 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹43.01 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-147.3%
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Neoaska Pharma Private Limited, buy the company report.

Board of directors of Neoaska Pharma Private Limited

Neoaska Pharma has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Nagaraja Rathan YancharlaDirector13 Jul 20233 Years 3 MonthsCurrent
Pakanati Venkata Raghava ReddyAdditional Director01 Dec 20232 Years 11 MonthsCurrent

Peer comparison

Neoaska Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Soranus Lifesciences Private Limited₹3.26 Lakh (FY 2024)-31.0%Ahmedabad, Gujarat, India
Lakshmi Healthcare Products Private Limited₹3.25 Lakh (FY 2024)-93.0%Khurda, Odisha, India
Aamidex Healthcare Private Limited₹3.25 Lakh (FY 2025)-72.0%Mayur Vihar Ph, Delhi, India
Fysan Pharmaceuticals Private Limited₹3.22 Lakh (FY 2020)-62.0%Pune, Maharashtra, India
Rhone Pharmacie Private Limited₹3.2 Lakh (FY 2024)14.0%New Delhi, Delhi, India
Neoaska Pharma Private Limitedthis company₹3.17 Lakh (FY 2025)-₹43.01 Lakh-53.0%30Hyderabad, Telangana, India
Global Hemo Care Private Limited₹3.17 Lakh (FY 2024)104.0%Parwanoo, Himachal Pradesh, India
Geion Formulations Private Limited₹3.16 Lakh (FY 2023)Hyderabad, Telangana, India
Blue Shield Healthcare (I) Private Limited₹3.11 Lakh (FY 2025)-40.0%Navi Mumbai, Maharashtra, India
Heetul Graphics Pvt Ltd₹3.09 Lakh (FY 2025)-73.0%Anand, Gujarat, India
Vitmio Pharmaceuticals Private Limited₹3.09 Lakh (FY 2025)Ambarnath, Maharashtra, India

To see the full peer comparison of Neoaska Pharma Private Limited, buy the company report.

Auditor

Neoaska Pharma Private Limited is audited by M V NARAYANA REDDY & CO for the financial year 2019.

Auditor firmFinancial yearFirm registration number
M V NARAYANA REDDY & COFY 2019002370S

Shareholding

The shareholding of Neoaska Pharma Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Neoaska Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹18.96 Cr
Breakdown by lending institutions
Others₹18.96 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
01 Oct 2019100297367Others₹18.96 CrSatisfied

To see the full charge records of Neoaska Pharma Private Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Neoaska Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Neoaska Pharma Private Limited has a workforce of 30 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.

Employee count
30
Active EPFO establishments
1
Employee growth
87.5%

GST

Neoaska Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AAFCN8041A1ZSTelanganaActive13 Nov 2018

To see the full GST registrations and return filing status of Neoaska Pharma Private Limited, buy the company report.

Recent activity

Neoaska Pharma Private Limited has 10 board changes on record since 2020: 2 appointments and 8 cessations. The latest: Pakanati Venkata Raghava Reddy was appointed as Additional Director on 01 Dec 2023.

AGM
Neoaska Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Neoaska Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Pakanati Venkata Raghava Reddy was appointed as Additional Director.
Ceased
Sharan Alla ceased to be Director.
Charges
A charge registered on 01 Oct 2019 via Charge ID 100297367 with Others was fully satisfied on 18 Aug 2023.
Ceased
Bavaguthu Raghuram Shetty ceased to be Director.
Appointed
Nagaraja Rathan Yancharla was appointed as Director.
Ceased
Shireesh Shetty ceased to be Additional Director.
Ceased
Shishir Shetty ceased to be Additional Director.
Charges
A charge with Others of Rs. 18.96 Cr registered on 01 Oct 2019 with Charge ID 100297367 was modified on 18 May 2022.
Ceased
Kazuhiko Kato ceased to be Director.
Ceased
Norimichi Okubo ceased to be Director.

4 earlier events are in the company report.

Frequently asked questions

Neoaska Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 October 2017 (9+ years old) and is registered under CIN U74999TG2017PTC119969.

Neoaska Pharma has 2 current directors:

The latest financial statements of Neoaska Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Neoaska Pharma is 36AAFCN8041A1ZS, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Neoaska Pharma is U74999TG2017PTC119969. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Neoaska Pharma has 12 court cases on record: 1 filed by the company and 11 filed against it. 2 are pending. Most are in the nclat.

Neoaska Pharma was incorporated on 10 October 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.

The peers of Neoaska Pharma by revenue are Soranus Lifesciences Private Limited, Lakshmi Healthcare Products Private Limited, Aamidex Healthcare Private Limited, Fysan Pharmaceuticals Private Limited, Rhone Pharmacie Private Limited and 5 more, all in the Pharma industry (Formulations).

Pakanati Venkata Raghava Reddy was appointed as Additional Director on 01 Dec 2023. Sharan Alla ceased to be Director on 01 Dec 2023. Bavaguthu Raghuram Shetty ceased to be Director on 13 Jul 2023. Neoaska Pharma has 10 board changes on record in total.

Neoaska Pharma can be reached through the website tatvalegal.com. Its registered office is in Hyderabad, Telangana, India.

The registered office of Neoaska Pharma is at Door No 1 – 661Ceo1Ph Plot No 1 Ceo Enclave, Sy No. 1362 And 1364 Gachibowli Hyderabad, Telangana, India – 500032.